Stockscreener 앱 받기
0.1329
0.45%
-0.0006
시간 외 거래:
.12
-0.0129
-9.71%
전일 마감가:
$0.1335
열려 있는:
$0.1295
하루 거래량:
205.42K
Relative Volume:
0.09
시가총액:
$769.64K
수익:
$7.84M
순이익/손실:
$-55.03M
주가수익비율:
-0.0627
EPS:
-2.12
순현금흐름:
$-41.00M
1주 성능:
-10.63%
1개월 성능:
-11.75%
6개월 성능:
-81.92%
1년 성능:
+0.00%
1일 변동 폭
$0.1295
$0.1424
1주일 범위
$0.1152
$0.154
52주 변동 폭
$0.1152
$7.2192
Scorpius Holdings Inc Stock (SCPX) Company Profile
SCPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCPX
Scorpius Holdings Inc
|
0.1329 | 769.64K | 7.84M | -55.03M | -41.00M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Scorpius Holdings Inc 주식(SCPX)의 최신 뉴스
Scorpius Holdings Delays 10-K Filing Amid Time Constraints - TipRanks
Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC - MarketScreener
Scorpius Holdings announces executive employment updates By Investing.com - Investing.com Australia
Scorpius Holdings announces executive employment updates - Investing.com
Scorpius Holdings Updates Executive Employment Agreements - TipRanks
Scorpius Holdings cuts costs with strategic lease assignment By Investing.com - Investing.com South Africa
Scorpius Holdings cuts costs with strategic lease assignment - Investing.com
Scorpius Holdings expands board, appoints new director By Investing.com - Investing.com South Africa
Scorpius Holdings Expands Board with New Appointment - TipRanks
Scorpius Holdings expands board, appoints new director - Investing.com
Scorpius engages Alliance Global Partners to explore strategic alternatives - MSN
Scorpius Holdings, Inc. announced that it has received $0.6 million in funding -February 25, 2025 - Marketscreener.com
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives - GlobeNewswire
SCPXScorpius Holdings Latest Stock News & Market Updates - StockTitan
Is Scorpius Holdings Preparing for a Sale? CDMO Taps Financial Advisor for Strategic Review - StockTitan
Scorpius Holdings secures $1 million promissory note - MSN
Healthy Upside Potential: Scorpius Holdings Inc (SCPX) - SETE News
Company’s Banking Stock: Dissecting a -67.36% Quarterly Revenue Decline Amid Growth - The InvestChronicle
A stock that deserves closer examination: Scorpius Holdings Inc (SCPX) - US Post News
Closing Figures Unveiled: Scorpius Holdings Inc (SCPX) Drop -7.47, Closes at 0.25 - The Dwinnex
Market Momentum Report: Lyell Immunopharma Inc (LYEL)’s Negative Close at 0.58 - The Dwinnex
Scorpius Holdings secures $600,000 through promissory note - MSN
Scorpius Holdings secures $600,000 through promissory note By Investing.com - Investing.com Australia
Heat Biologics, Inc. Announces the Promotion of William Ostrander to Chief Financial Officer - Marketscreener.com
Heat Biologics, Inc. Announces Promotions of Taylor Schreiber to Chief Scientific Officer and Melissa Price to Vice President of Product Development - Marketscreener.com
Scorpius CEO acknowledges agreement with state to build Manhattan facility is 'no more' - themercury.com
Scorpius Holdings, Inc. Launches Scorpius Ventures -November 19, 2024 at 07:30 am EST - Marketscreener.com
Scorpius Holdings, Inc. announced that it has received $0.225 million in funding -November 26, 2024 - Marketscreener.com
Scorpius Holdings, Inc. announced that it expects to receive $12.05 million in funding -December 04, 2024 - Marketscreener.com
Scorpius Holdings Set to Launch First Mammalian Cgmp Campaign At San Antonio Facility in the 2024 3Rd Quarter - Marketscreener.com
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™ - GlobeNewswire
Scorpius Partners with KaloCyte on Revolutionary Artificial Blood Cell Manufacturing - StockTitan
Scorpius Partners with KaloCyte to Enhance Manufacturing Efficiencies for ErythroMer - Contract Pharma
Scorpius announces 1-for-20 reverse stock split - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Scorpius Holdings Cancels Planned Reverse Stock Split - GlobeNewswire
Scorpius Holdings Cancels Planned 1-for-20 Reverse Stock Split in Surprise Move - StockTitan
Nasdaq Surges Over 300 Points; State Street Earnings Top Views - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Scorpius Holdings Implements Reverse Stock Split Strategy - TipRanks
Scorpius Holdings Announces Reverse Stock Split - The Manila Times
Scorpius Holdings Announces 1-for-20 Reverse Stock Split to Maintain NYSE American Listing - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Scorpius Holdings faces funding challenges, seeks capital By Investing.com - Investing.com Canada
Scorpius Holdings faces funding challenges, seeks capital - Investing.com
Scorpius Holdings Readies Public Offering Amid Going-Concern Warning - MarketWatch
Form PRE 14A Scorpius Holdings, Inc. For: Jan 16 - StreetInsider.com
Scorpius Holdings, Inc. announced that it expects to receive $12.05 million in funding - Marketscreener.com
Scorpius Holdings Inc (SCPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):